Non-anonymized images will only be provided if the images will be “assessed as part of clinical decision making,” otherwise anonymized images will be provided. If this is the case, the clinician must indicate this on the request form.
Non-anonymized CD will be burned and available for pick-up at VA ROI within 48hrs.
Clinical service walks CD to the UW file room (F2/4), where it is loaded into UW PACS within a few minutes of receipt of CD.
File room hours:
24/7 during the week
7:30am-3:30pm on weekends
Not staffed on holidays
On pager 6359 for emergencies
Alternatively, clinical service can load study into PACS through the designated computer in the Emergency Department. If that is unsuccessful, however, the file room staff have alternative methods of loading most non-anonymized studies into PACS.
If transfer needed sooner, then…
Follow steps described above, requesting need for “expedited” processing. CD should be available from VA ROI within 2-3 hours of request.
If not during normal business hours or quicker turn-around time necessary, call imaging technologist on duty (cell phone (608) 308-3444) to request CD.
The purpose of this memo is to provide an update on the status of pre-MRI safety screening in patients who may have had hemostasis clips placed during endoscopy or colonscopy. The concern is that torqueing of a ferromagnetic hemostasis clip
in a strong magnetic field could lead to bleeding or injury at the site of biopsy/polypectomy.
The purpose of this document is to establish departmental guidelines for administration of ferumoxytol as a contrast agent for patients undergoing MRI.
The purpose of this document is to establish a systematic approach for safely performing MRI exams of patients with metallic implants of uncertain identity. In all MRI facilities, a recurring challenge occurs whereby MRI safety screening procedures identify a patient with an implanted metallic object of uncertain/unknown identity. Despite the best attempts of the MRI safety team, there are many situations where accurate identification of the implant cannot be determined.
The purpose of this memorandum is to describe the appropriate use of pulmonary MRA for the diagnosis of pulmonary embolus in patients with dyspnea and/or chest pain, including the appropriate use of pulmonary MRA in pregnant patients.